We provide you with 20 years of free, institutional-grade data for TARA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TARA. Explore the full financial landscape of TARA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Protara Therapeutics, Inc(NASDAQ:TARA) 
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformation...
Share this website to your friends
The information provided in this report about TARA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.